HealthEquity, Inc. (HQY)

HealthEquity Income Statement

Financials in millions USD. Fiscal year is February - January.

Year	2023	2022	2021	2020	2019
Revenue	999.59	861.75	756.56	733.57	531.99
Revenue Growth (YoY)	16.00%	13.90%	3.13%	37.89%	85.21%
Cost of Revenue	376.95	369.81	331.79	318.24	206.08
Gross Profit	622.64	491.94	424.77	415.33	325.91
Selling, General & Admin	182.93	166.32	144.04	134.46	104.51
Research & Development	218.81	193.38	157.36	124.81	77.58
Other Operating Expenses	103.2	123.18	147.6	122.05	66.82
Operating Expenses	504.94	482.88	449	381.32	248.9
Operating Income	117.7	9.06	-24.24	34.01	77.01
Interest Expense / Income	55.46	48.42	36.57	34.88	24.77
Other Expense / Income	-12.8	-1.27	5.93	-5.01	9.08
Pretax Income	75.04	-38.1	-66.74	4.14	43.16
Income Tax	19.33	-11.95	-22.45	-4.69	3.49
Net Income	55.71	-26.14	-44.29	8.83	39.66
Net Income Growth	-	-	-	-77.73%	-46.33%
Shares Outstanding (Basic)	86	84	83	74	67
Shares Outstanding (Diluted)	87	84	83	76	68
Shares Change	2.98%	1.57%	9.85%	10.56%	8.02%
EPS (Basic)	0.65	-0.31	-0.53	0.12	0.59
EPS (Diluted)	0.64	-0.31	-0.53	0.12	0.58
EPS Growth	-	-	-	-79.31%	-50.43%
Free Cash Flow	200.01	102.11	69.38	117.03	72.07
Free Cash Flow Per Share	2.34	1.21	0.83	1.58	1.07
Gross Margin	62.29%	57.09%	56.14%	56.62%	61.26%
Operating Margin	11.77%	1.05%	-3.20%	4.64%	14.48%
Profit Margin	5.57%	-3.03%	-5.85%	1.20%	7.46%
Free Cash Flow Margin	20.01%	11.85%	9.17%	15.95%	13.55%
Effective Tax Rate	25.76%	-	-	-113.38%	8.09%
EBITDA	283.57	171.53	107.02	154.93	123.28
EBITDA Margin	28.37%	19.90%	14.15%	21.12%	23.17%
Depreciation & Amortization	153.08	161.2	137.19	115.9	55.35
EBIT	130.5	10.33	-30.17	39.02	67.93
EBIT Margin	13.05%	1.20%	-3.99%	5.32%	12.77%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).